Tag: Biotechnology
Risk analysis plan: Brussels wants to protect critical technologies
Risk analysis plan Brussels wants to protect critical technologies October 3, 2023, 5:51 p.m Listen to article This audio version was artificially generated. More info | Send feedback In the…
Production planned by 2030: Moderna is developing a cancer vaccine
Production planned until 2030 Moderna is developing a cancer vaccine 04/08/2023, 10:30 p.m Research on cancer vaccines is in full swing worldwide. In addition to the Mainz-based biotechnology company Biontech,…
Innate pharma: Data published in Nature Biotechnology
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Innate Pharma: data published in Nature Biotechnology
(CercleFinance.com) – Innate Pharma announces the publication in Nature Biotechnology of preclinical data showing the control of acute myeloid leukemia (AML) cells by a trifunctional antibody engaging NK cells (Natural…
Innate Pharma: data published in Nature Biotechnology – 01/16/2023 at 07:25
(CercleFinance.com) – Innate Pharma announces the publication in Nature Biotechnology of preclinical data showing the control of acute myeloid leukemia (AML) cells by a trifunctional antibody engaging NK cells (Natural…
InstaDeep is the largest acquisition: Biontech buys British AI startup
InstaDeep is the largest acquisition Biontech buys British AI startup 01/10/2023, 4:55 p.m Biontech wants to expand its capacities in the field of immunotherapies. To do this, the Mainz-based company…
Positive study data: ray of hope for Curevac – share price picks up again
Positive study data Ray of hope for Curevac – share price picks up again 1/9/2023 4:43 p.m Curevac is repositioning itself at the top. The new combined vaccination against influenza…
Plectonic Biotech? We are developing the microsurgical scalpel for cancer therapy, says founder Wagenbauer
Founder Wagenbauer in conversation Plectonic is researching the “scalpel” of cancer therapies 12/28/2022, 9:08 am Plectonic Biotech wants to revolutionize cancer treatment: The biotech startup wants to build small nanoswitches…
Novozymes swallows Chr. Hansen to form a biotechnology heavyweight
The operation values Chr. Hansen at 660 Danish crowns per share, or 86 billion crowns (about 11.5 billion euros). The Danish biotechnology groups Novozymes and Chr. Hansen announced on Monday…
With a salary of $ 700,000: Moderna CFO has to leave after two days
With a salary of $700,000 Moderna chief financial officer to leave after two days 5/11/2022, 5:41 p.m Shortly after taking office as the new CFO of Moderna, Jorge Gomez has…
Cooperation with Medigene: Biontech plans cooperation in cancer therapy
Cooperation with Medigene Biontech plans collaboration on cancer therapy 2/21/2022, 9:57 p.m Biontech gets the expertise of another company for research on cancer immunotherapies. Medigene offers a novel program to…
Biontech starts production: Omikron vaccine should be available from March
Tuesday, January 11, 2022 Biontech starts production Omikron vaccine should be available from March The authorities have not yet decided whether an adapted vaccine is required because of the Omikron…